Janus Henderson Global Life Sciences N
- JFNNX
- Price as of: Apr 16, 2021
-
$70.39
N/A N/A
- Primary Theme
- Health Care Sector Equity
- Fund Company
- Janus
- Share Class
JFNNX - Snapshot
Vitals
- YTD Return -1.0%
- 3 Yr Annualized Return 16.8%
- 5 Yr Annualized Return 15.5%
- Net Assets $4.77 B
- Holdings in Top 10 28.4%
52 WEEK LOW AND HIGH
Expenses
OPERATING RELATED FEES
- Expense Ratio 0.67%
SALES FEES
- Front Load N/A
- Deferred Load N/A
BROKERAGE FEES
- Turnover 43.00%
TRADING FEES
- Max Redemption Fee N/A
Min Investment
- Standard (Taxable) $1,000,000
- IRA N/A
Fund Classification
-
Primary Theme
Health Care Sector Equity
- Fund Type Open End Mutual Fund
- Investment Style Health
JFNNX - Profile
Distributions
- YTD Total Return -1.0%
- 3 Yr Annualized Total Return 16.8%
- 5 Yr Annualized Total Return 15.5%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 1.08%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameJanus Henderson Global Life Sciences Fund
-
Fund Family NameJanus Henderson
-
Inception DateJan 26, 2018
-
Shares OutstandingN/A
-
Share ClassN
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerAndrew Acker
Fund Description
The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.
JFNNX - Performance
Return Ranking - Trailing
Period | JFNNX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -1.0% | -46.5% | 19.7% | 80.92% |
1 Yr | 41.7% | 21.1% | 184.4% | 38.79% |
3 Yr | 16.8%* | 1.3% | 54.0% | 21.92% |
5 Yr | 15.5%* | 5.2% | 40.3% | 30.00% |
10 Yr | 17.6%* | 9.4% | 20.2% | 16.94% |
* Annualized
Return Ranking - Calendar
Period | JFNNX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2020 | 16.4% | -13.6% | 178.2% | 37.65% |
2019 | 21.5% | 3.8% | 63.8% | 43.84% |
2018 | N/A | -49.7% | 21.5% | N/A |
2017 | N/A | -59.8% | 54.4% | N/A |
2016 | N/A | -36.6% | 11.6% | N/A |
Total Return Ranking - Trailing
Period | JFNNX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -1.0% | -46.5% | 19.7% | 80.92% |
1 Yr | 41.7% | 14.7% | 184.4% | 35.76% |
3 Yr | 16.8%* | 1.3% | 54.0% | 20.55% |
5 Yr | 15.5%* | 5.0% | 40.3% | 27.14% |
10 Yr | 17.6%* | 9.3% | 20.2% | 16.94% |
* Annualized
Total Return Ranking - Calendar
Period | JFNNX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2020 | 16.4% | -13.6% | 178.2% | 37.65% |
2019 | 21.5% | 3.8% | 63.8% | 43.84% |
2018 | N/A | -25.3% | 22.2% | N/A |
2017 | N/A | -10.8% | 54.4% | N/A |
2016 | N/A | -36.6% | 11.6% | N/A |
NAV & Total Return History
JFNNX - Holdings
Concentration Analysis
JFNNX | Category Low | Category High | JFNNX % Rank | |
---|---|---|---|---|
Net Assets | 4.77 B | 2.48 M | 47.6 B | 17.71% |
Number of Holdings | 120 | 26 | 450 | 21.71% |
Net Assets in Top 10 | 1.42 B | 239 K | 19.6 B | 20.00% |
Weighting of Top 10 | 28.40% | 7.6% | 77.3% | 82.86% |
Top 10 Holdings
- UnitedHealth Group Inc 3.54%
- AstraZeneca PLC 3.36%
- AstraZeneca PLC 3.36%
- AstraZeneca PLC 3.36%
- AstraZeneca PLC 3.36%
- AstraZeneca PLC 3.36%
- AstraZeneca PLC 3.36%
- AstraZeneca PLC 3.36%
- AstraZeneca PLC 3.36%
- AstraZeneca PLC 3.36%
Asset Allocation
Weighting | Return Low | Return High | JFNNX % Rank | |
---|---|---|---|---|
Stocks | 92.05% | 82.92% | 105.23% | 93.71% |
Other | 7.17% | -26.63% | 10.48% | 5.14% |
Cash | 0.78% | -0.23% | 10.92% | 45.71% |
Preferred Stocks | 0.00% | 0.00% | 5.58% | 65.71% |
Convertible Bonds | 0.00% | 0.00% | 0.02% | 58.29% |
Bonds | 0.00% | 0.00% | 18.37% | 61.14% |
Stock Sector Breakdown
Weighting | Return Low | Return High | JFNNX % Rank | |
---|---|---|---|---|
Healthcare | 99.90% | 22.48% | 100.00% | 32.00% |
Financial Services | 0.10% | 0.00% | 10.87% | 39.43% |
Utilities | 0.00% | 0.00% | 1.24% | 58.29% |
Technology | 0.00% | 0.00% | 27.24% | 66.86% |
Real Estate | 0.00% | 0.00% | 6.18% | 62.86% |
Industrials | 0.00% | 0.00% | 4.84% | 64.00% |
Energy | 0.00% | 0.00% | 0.03% | 58.86% |
Communication Services | 0.00% | 0.00% | 13.83% | 61.14% |
Consumer Defense | 0.00% | 0.00% | 30.57% | 59.43% |
Consumer Cyclical | 0.00% | 0.00% | 14.05% | 62.86% |
Basic Materials | 0.00% | 0.00% | 3.70% | 73.71% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | JFNNX % Rank | |
---|---|---|---|---|
US | 73.79% | 58.67% | 101.51% | 78.86% |
Non US | 18.26% | 0.00% | 40.32% | 25.71% |
JFNNX - Expenses
Operational Fees
JFNNX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.67% | 0.08% | 25.14% | 77.06% |
Management Fee | 0.64% | 0.00% | 1.25% | 52.00% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | 0.12% | 0.03% | 0.25% | 57.14% |
Sales Fees
JFNNX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
JFNNX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
JFNNX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 43.00% | 0.70% | 252.00% | 53.33% |
JFNNX - Distributions
Dividend Yield Analysis
JFNNX | Category Low | Category High | JFNNX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 0.97% | 65.14% |
Dividend Distribution Analysis
JFNNX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Annually | Annually |
Net Income Ratio Analysis
JFNNX | Category Low | Category High | JFNNX % Rank | |
---|---|---|---|---|
Net Income Ratio | 1.08% | -2.53% | 1.74% | 7.60% |
Capital Gain Distribution Analysis
JFNNX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
JFNNX - Fund Manager Analysis
Managers
Andrew Acker
Start Date
Tenure
Tenure Rank
May 01, 2007
13.93
13.9%
Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.04 | 23.56 | 7.25 | 20.93 |